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Abstract: Magnetotactic bacteria (MTB) produce intracellular organelles called magnetosomes 
which are magnetic nanoparticles composed of magnetite (Fe3O4) or greigite (Fe3S4) 
enveloped by a lipid bilayer. The synthesis of a magnetosome is through a genetically 
controlled process in which the bacterium has control over the composition, direction of 
crystal growth, and the size and shape of the mineral crystal. As a result of this control, 
magnetosomes have narrow and uniform size ranges, relatively specific magnetic and 
crystalline properties, and an enveloping biological membrane. These features are not 
observed in magnetic particles produced abiotically and thus magnetosomes are of great 
interest in biotechnology. Most currently described MTB have been isolated from saline  
or brackish environments and the availability of their genomes has contributed to a  
better understanding and culturing of these fastidious microorganisms. Moreover, genome 
sequences have allowed researchers to study genes related to magnetosome production for 
the synthesis of magnetic particles for use in future commercial and medical applications. 
Here, we review the current information on the biology of MTB and apply, for the first time, 
a genome mining strategy on these microorganisms to search for secondary metabolite 
synthesis genes. More specifically, we discovered that the genome of the cultured MTB 
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Magnetovibrio blakemorei, among other MTB, contains several metabolic pathways for the 
synthesis of secondary metabolites and other compounds, thereby raising the possibility of 
the co-production of new bioactive molecules along with magnetosomes by this species. 
Keywords: biomineralization; bioproducts; genome mining; greigite; magnetite; 
magnetosomes; magnetotactic bacteria; Magnetovibrio blakemorei; nonribosomal peptide 
synthetase; polyketide synthase 
 
1. Introduction 
Magnetotactic bacteria (MTB) are a morphologically, phylogenetically, and metabolically diverse 
group of prokaryotes that share the ability to biomineralize intracellular magnetic nanocrystals 
surrounded by a lipid bilayer (biological membrane) [1]. These structures, referred to as magnetosomes, 
are usually organized in one or more chains within the cell, function as a miniature biological compass 
needle thereby causing cells of MTB to orient and subsequently swim along magnetic field lines [1]. 
Magnetosome crystals are either composed of the iron oxide, magnetite (Fe3O4), or the iron sulfide, 
greigite (Fe3S4), depending on the species. Usually one species of MTB synthesizes magnetosome 
crystals of one specific composition, magnetite or greigite, although several species synthesize both 
minerals [2,3]. MTB mainly occur in aquatic ecosystems ranging from freshwater to hypersaline 
environments. Most MTB are microaerophilic with regard to oxygen, although there are some obligately 
anaerobic strains usually found at or below the oxic-anoxic interface of chemically stratified water 
columns or sediments [1]. While magnetite-producing MTB are generally found at the oxic-anoxic 
interface, greigite synthesizers inhabit more anoxic zones where sulfide is present [4]. 
All MTB described so far phylogenetically belong to the domain Bacteria. Most species  
belong to several classes in the Proteobacteria phylum including the Alpha-, Delta- and  
Gammaproteobacteria [5–7]. A number of uncultured MTB belonging to the Nitrospirae phylum and 
the Planctomycetes-Verrucomicrobia-Chlamydiae (PVC) superphylum have also been described [8–10]. 
Cell morphologies of MTB include cocci, rods, spirilla, vibrios, barbell-shaped and multicellular forms. 
Despite their phylogenetic and morphological diversity, relatively few MTB are currently maintained in 
axenic cultures. 
Recognized cultured spirillar MTB belonging to the genus Magnetospirillum in the Alphaproteobacteria 
were all isolated from freshwater habitats: the most studied species of this genus include  
Ms. gryphiswaldense [11], Ms. magneticum [12], Ms. magnetotacticum [13]. Isolated strains from 
marine or brackish environments include: the coccoid strains MO-1 [14], Magnetococcus marinus strain 
MC-1 [15] and Magnetofaba australis (IT-1) [16]; the vibrioid strain Magnetovibrio blakemorei strain 
MV-1 [17] and the spirilla Magnetospira thiophila (MMS-1) [18] and Magnetospira sp. strain QH-2 [19]; 
all of which belong to the Alphaproteobacteria. Deltaproteobacterial MTB found in marine habitats 
include the multicellular forms: Candidatus Magnetoglobus multicellularis, from a hypersaline lagoon 
connected to the sea [20]; Candidatus Magnetananas tsingtaoensis from an intertidal zone [21]; and 
Candidatus Magnetomorum litorale from the North Sea [22]. Deltaproteobacterial MTB also include the 
freshwater Desulfovibrio magneticus strain RS-1 [23] and a species from a brackish environment 
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Candidatus Desulfamplus magnetomortis strain BW-1 [24]. There are two species of cultivated MTB 
belonging to the Gammaproteobacteria, strains BW-2 and SS-5, isolated from a brackish and a 
hypersaline environment, respectively [25]. 
The composition and morphology of magnetosome crystals is species specific and is strongly 
correlated with the phylogeny of MTB [26], evidence that there is strong genetic control involved in 
magnetosome biomineralization. Each magnetosome consists of a magnetic crystal surrounded by a lipid 
bilayer that originates from the cell (cytoplasmic) membrane, but has a different protein composition [27]. 
Several proteins, considered unique to MTB, are located in or close to the magnetosome membrane 
(MM) and appear to control crystal nucleation, growth, and the organization of magnetosomes within 
the cell [28]. Each species has control over the composition, direction of crystal growth in elongated 
particles, and the size and shape of its own magnetosome mineral crystals. However, the local 
environment clearly influences magnetosome synthesis since it has been shown in culture, for example, 
that different concentrations of oxygen and iron affect magnetosome composition, crystal size, and 
crystallographic properties [29–31]. 
Biogenically-produced magnetosomes present unique features that are difficult to obtain through  
the chemical synthesis of abiotically-produced magnetic nanocrystals. These characteristics include:  
a narrow, single magnetic domain, nanosize range; a strong degree of crystallographic perfection;  
a permanent magnetization; and the presence of a biocompatible lipid bilayer around each mineral 
particle [32,33]. All these characteristics have outstanding importance in biotechnological applications 
of magnetic nanoparticles such as contrast for nuclear magnetic resonance (NMR), in cell separation 
assays, as drug carriers and in the destruction of tumor cells by hyperthermia [34–37]. 
The main shortcoming for the application of magnetosomes is the requirement for large amounts of 
material through the mass culture of MTB. Although in general MTB are fastidious with regard to 
growth, the cultivation in large bioreactors has already been established for freshwater strains of 
Magnetospirillum [38] and the marine vibrio Magnetovibrio blakemorei [39]. The major goal is to 
increase magnetosome production while decreasing the cost of the cultivation of MTB. One methodology 
to avoid this problem is to transfer the genetic capability to biomineralize magnetosomes to a more 
easily-grown non-magnetotactic bacterium. This has now been established in the photosynthetic 
alphaproteobacterium Rhodospirillum rubrum [40] although large-scale production of magnetosomes by 
heterologous expression in this organism has not yet been tested. Another strategy to increase the 
feasibility of the industrial production of magnetosomes is to co-produce compounds of high  
added-value in the process since the magnetic properties of the nanocrystals facilitate their separation. 
The availability of a number of genomes from MTB has enabled searches for genes encoding biosynthetic 
pathways not detected under currently applied culture conditions. 
Here, we review recently acquired knowledge regarding MTB, magnetosome biomineralization,  
and their mass production in bioreactors and technological applications where magnetosomes might be 
superior compared to currently used materials. We also searched for conserved domains of genes in  
the genomes of MTB that encode the production of secondary metabolites thereby targeting strains of 
MTB with the potential to produce high added-value compounds. 
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2. Biology of MTB and Their Magnetosomes 
2.1. Ecology and Physiology of MTB 
As previously stated, MTB are a diverse group in terms of phylogeny, morphology and physiology, 
but share the ability to biomineralize magnetosomes usually organized in chains within the cell [1].  
Other characteristic features of MTB are a Gram-negative cell wall, motility through the action of 
flagella, and a negative tactic and growth response to atmospheric concentrations of oxygen [41].  
The most abundant morphotype of MTB in natural environments are the magnetotactic cocci (Figure 1). 
These are often detected in large numbers in chemically-stratified water columns or sediments. Other 
morphologies of MTB include spirilla, rods, vibrios of various dimensions, and the morphologically 
conspicuous multicellular aggregates [6]. 
 
Figure 1. Differential interference contrast (DIC) microscopy image of magnetotactic 
bacteria (MTB) collected from the Itaipu Lagoon, a brackish lagoon connected to the 
Atlantic Ocean in Brazil. Cells respond strongly to an applied magnetic field and in very 
large cells it is possible to observe the chain of magnetosomes (shown at arrowheads).  
Most cells have a coccoid to bean-shaped morphology and cell inclusions other than 
magnetosomes are visible in some cells (shown at arrows). 
MTB are generally ubiquitous in aquatic environments [6] and at least once were detected in wet  
soils [42]. They are usually found in or below the oxic-anoxic transition zone in stratified water columns 
or sediments [41]. Their occurrence in deep-sea sediments has also been documented [43]. Most cultured 
MTB were isolated from freshwater or brackish sediments at ambient temperature (these MTB are 
mesophilic) although their ecological distribution includes saline, hypersaline, polar, thermal, and 
extreme alkaline habitats [44] (Figure 2). There is evidence that the richness and diversity of MTB in 
different environments is strongly influenced by salinity [45,46] although temperature, iron availability 
and concentrations of nitrogen and sulfur compounds are also clearly important in the distribution of 
MTB [46–49]. The numbers of MTB cells is any environment is very variable: Their abundance in some 
marine sediments has been estimated at 104 cells mL−1 and 106 cells mL−1 in some saline lakes [50]. 
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Metabolically, many MTB are capable of chemolithoautotrophy and chemoorganoheterotrophy and 
most species are capable of fixing atmospheric nitrogen. All species appear to take up iron very 
efficiently and due to the synthesis of magnetosomes, MTB may accumulate up to 100 times more  
iron than other non-magnetotactic heterotrophic bacteria [51]. MTB play significant roles in the 
biogeochemical cycles not only of iron through magnetosome biomineralization but also of carbon, 
nitrogen, and sulfur through chemolithoautotrophy. 
 
Figure 2. Phylogenetic tree of known MTB based on their 16S rRNA gene sequences.  
The tree was constructed using the Neighbor Joining method [52] using MEGA software 
version 5.2 [53]. Taxa in bold type indicate cultured strains, whereas taxa in plain type 
indicate described but uncultured strains. Accession numbers are given between brackets. 
Symbols alongside taxa names indicate the environmental type of the strain and the availability 
of complete or partial genome sequences, as indicated in the accompanying legend. 
The best described marine magnetotactic species, the euryhaline Magnetovibrio blakemorei,  
exhibits perhaps the widest metabolic diversity. It is capable of chemolithoautotrophic growth using 
thiosulfate or sulfide and CO2 as electron donors and carbon source, respectively. It also grows 
chemoorganoautotrophically using formate as electron donor and CO2 as carbon source, and 
Mar. Drugs 2015, 13 394 
 
 
chemoorganoheterotrophically using diverse organic acids, amino acids, casamino acids, peptone,  
yeast extract, and tryptone as sources of electrons and carbon. Autotrophy is through the  
Calvin-Benson-Bassham cycle [17,54]. It grows under both microaerophilic and anaerobic conditions 
using oxygen, nitrate or nitrous oxide as terminal electron acceptors. Mv. blakemorei is the only known 
magnetotactic strain capable of growing with both nitrous oxide and nitrate as electron acceptors  
and fixes nitrogen as well, suggesting that this species plays a significant role in the cycling of nitrogen 
in marine environments particularly where N2O is available as a product of denitrifying bacteria  
and from ammonia-oxidizing Archaea and Bacteria [17,55]. The closer phylogenetic relatives to  
Mv. blakemorei are the Magnetospira strains. Magnetospira thiophila strain MMS-1 is also capable of 
chemolithoautotrophic and chemoorganoheterotrophic growth but uses only oxygen as an electron 
acceptor [18]. Thiosulfate is the only known electron donor for autotrophic growth and this species has 
a much narrower range of organic substrates for chemoorganoheterotrophic growth restricted to the 
organic acids acetate, fumarate, malate, and succinate [18]. Genomic data and growth studies indicate 
that Magnetospira strain QH-2 grows chemoorganoheterotrophically using acetate, citrate, succinate, 
malate, and fumarate as sources of electrons and carbon but can only respire with O2 as a terminal 
electron acceptor [56]. Although autotrophic growth has not been demonstrated for this species,  
its genome contains two forms of ribulose-1,5-bisphosphate caboxylase/oxygenase (RubisCO) genes 
(Forms IAq and II) suggesting that it is able to utilize the Calvin-Benson-Bassham cycle for autotrophy. 
Alternatively, there is evidence that the reverse tricarboxylic acid (rTCA) cycle might also be used to 
fix CO2 [56]. The genome of Magnetospira sp. strain QH-2 contains a number of specific genes that 
appear to be related to its adaptation to saline environments [56]. 
All described magnetotactic cocci belong to the Alphaproteobacteria class representing a clade  
that is phylogenetically basal to the Alphaproteobacteria [15]. Of this very large group, there are  
only three cultured strains. All are marine and include: Magnetococcus marinus strain MC-1 [15],  
strain MO-1 [14], and Magnetofaba australis strain IT-1 isolated from brackish sediment [16].  
While cells of strain MO-1 grow only under chemolithoautotrophic conditions with thiosulfate as 
electron donor using oxygen as an electron acceptor, Mf. australis and Mc. marinus display both 
chemorganoheterotrophic and chemolithoautotrophic growth. Autotrophy in Mc. marinus is through  
the rTCA cycle [57]. Magnetofaba australis strain IT-1 represents the first MTB isolated from the 
Southern Hemisphere and opens new possibilities to study the biomineralization process in strains  
from different Hemispheres and cell polarities [16]. 
Other marine strains of MTB are sulfate-reducing bacteria, belong to the Deltaproteobacteria class, 
are anaerobes and produce greigite [20] or greigite and magnetite [24]. 
2.2. Isolation and Cultivation of MTB 
The magnetic response of MTB to applied magnetic fields makes them easily detectable in natural 
samples and facilitates their separation from non-magnetotactic bacteria for further studies. Most 
descriptions of uncultured strains are based on morphological, phylogenetic, and genomic features 
determined by culture-independent analyses such as transmission electron microscopy, fluorescent  
in-situ hybridization and DNA sequencing (using polymerase chain reaction (PCR) with specific  
primers or single cell genomics) of cells separated from natural samples [10,20,58,59]. 
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Generally, most MTB collected from the Northern Hemisphere (North-seeking, NS) swim parallel to 
the magnetic field while those from the Southern Hemisphere (South-seeking, SS) swim antiparallel. 
This unusual characteristic has been exploited to a great degree in many studies in order to harvest MTB 
from the environment and obtain water samples highly enriched in MTB. The quantity and types of MTB 
present in natural habitats are strongly dependent on the presence of oxygen concentration gradients and 
other electron donors such as reduced sulfur compounds (e.g., sulfide) [41]. Increases in the number of 
specific morphotypes of MTB are often observed in natural samples (microcosms) kept under dim light 
(to prevent the overgrowth of photosynthetic organisms) and not subjected to mixing, thus stabilizing 
the oxygen and perhaps other chemical gradients in the sample. Artificial magnetic fields, typically using 
bar magnets, can be applied to the sample in order to induce MTB to swim in a desired direction for 
harvesting. Lins et al. [60] developed a glass apparatus with two opposite horizontal openings for which 
NS and SS-MTB are directed to swim when the apparatus, filled with water and sediment, is put inside 
a magnetic field-inducing coil connected to an energy supply. This electrified coil creates a 
homogeneous magnetic field in which MTB orient and migrate to the extremity of the openings from 
where they can be collected. However, this method does not prevent the migration of non-magnetotactic 
cells to the collection sites due to other tactic responses such as light or oxygen. To prevent this problem, 
separated cells are often further purified using the magnetic racetrack technique [61] which has now 
been modified [62]. This technique employs the use of glass Pasteur pipettes that have the thin opening 
sealed. A cotton plug is placed at the pipette neck and the entire pipette autoclaved. The pipette is filled 
with filter-sterilized water from the environment up to the cotton plug. Sediment and/or water containing 
MTB are then added to the wide opening end of the pipette. Magnets are placed close to each end of the 
pipette to direct MTB towards the closed end of the pipette. After a certain period of time, dependent 
upon the swimming speed of the MTB under study (typically 20–30 min), the sealed pipette tip can be 
broken and MTB collected at the extremity can be transferred to culture media or fixatives for 
microscopy, molecular, and other analyses [41]. 
Most known MTB appear to be gradient-requiring organisms and grow reasonably well in culture 
medium with an oxygen concentration gradient and low concentration of nutrients. Such cultures 
particularly designed for chemolithoautotrophs have been used successfully to isolate new MTB strains 
since fast growing heterotrophs outcompete fastidious MTB in richer media containing organic carbon 
sources. Cultured strains of MTB have been isolated using: colony formation, sometimes in shake tubes; 
repeated rounds of serial dilution to extinction; and magnetic enrichment [41]. Once a specific MTB has 
been isolated, growth can sometimes be enhanced by using richer heterotrophic media employing 
different organic and inorganic substrates and various electron acceptors. Growth rates as well as 
magnetosome production varies greatly even in the same strain depending whether the strain is  
cultured autotrophically or heterotrophically, aerobically or anaerobically, and with different carbon and 
iron sources used in the growth medium [29,63,64] (Table 1). Specific culture conditions are thus  
required for the mass scale production of cells and magnetosomes for biotechnological applications. As 
far as we know, only three magnetotactic strains are currently being mass cultured to high yields: the 
freshwater strains Magnetospirillum magneticum and Ms. gryphiswaldense and the marine vibrio  
Magnetovibrio blakemorei. 
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Table 1. Cultured strains of MTB and their magnetosome characteristics and production under different culture conditions. Numbers between 
brackets indicate the range of values for each parameter. 
Strain 
Bacterial Morphology Magnetosome 
References 
Shape 
Size (Length × 
Width) µm 
Crystal Shape  
and Composition 
Size (Length × 
Width) nm 
Number/Cell 







Spirillum 3 × 0.4–0.6  
Cuboctahedral 
magnetite 
No growth No growth 
41 ± 15 
12 ± 5 
(anaerobic) 
1.4 × 109 cells mL−1; 
2.6 mg L−1 magnetite 
(=2.8% cell weight) 
[12,29] 
SF = 0.78 
(anaerobic) 
33 ± 8.5 
SF = 0.89 




Spirillum 4–6 × 0.25 
Cuboctahedral 
magnetite 
No growth No growth 
42 (25–55) 
17.6 (5–41) 
0.2–0.6 g cell L−1 (wet 
weight) 
[13,65] 
SF = 0.9 
Magnetospirillum 
Gryphiswaldense MSR-1 




Ø 46 ± 6.8 (14–67) 
23.4 ± 0.9 
41.7 mg L−1  
(16.7 mg L−1 day−1) 
[66,67] 
SF = 0.91 
Magnetovibrio  
blakemorei MV-1 
Vibrio 1–3 × 0.2–0.4 
Elongated  
prismatic magnetite 
48 ± 5 (30–59) × 
26 ± 7 (28–40) 
17 ± 4  
(7–23) 
60 × 40 
15.34 ± 4 
15.14 mg L−1;  
(4.98 mg L−1 day−1) 
[39,68,69] 
AR = 1.8 ± 0.3 SF = 0.65 
Magnetospira  
thiophila MMS-1 




61 ± 12 (22–85) × 
52 ± 11 (18–80) 17 ± 5  
(8–31) 
NI [18,69] 
AR = 1.2 ± 0.1 




2.0 ± 0.4 (1–3) 




81 ± 23 × 58 ± 20 
SF = 0.71 ± 0.11 






1.4 ± 0.3 × 1.1 




6 ± 4  
(n = 100) 
83 ± 26 × 74 ± 23 10 ± 3  
(n = 100) 
NI [16] 
SF = 0.89 ± 0.05 
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Table 1. Cont. 
Magnetococcus  
marinus MC-1 




72 ± 11 (33–95) × 
70 ± 13 (29–87) 10 ± 2  
(6–15) 
83 ± 14 (30–110) × 
78 ± 11 (15–107) 14 ± 3  
(8–19) 
NI [15,69] 
AR=1.2 ± 0.2 
AR = 1.2 ± 0.1 
SF = 0.93 
Magnetococcus MO-1 Ovoid 





No growth No growth 
64 ± 20 × 57 ± 17 
17 ± 5 NI [14] 
SF = 0.89 
Strain BW-2 Rod 
4.4 ± 0.6 × 2.2 ± 0.2 
(n = 62) 
Cuboctahedral 
magnetite 
67 ± 16 × 63 ± 15 
30 ± 9  
(n = 46)  
No growth No growth NI [25] SF= 0.94 ± 0.04  
(n = 189) 
Strain SS-5 Rod 
2.5 ± 0.5 × 1.2 ± 0.1 
(n = 64) 
Elongated  
prismatic magnetite 
86 ± 27 × 63 ± 19 
20 ± 7  
(n = 45) 
NI NI  NI [25] SF = 0.74 ± 0.07  
(n = 171) 
Desulfovibrio magneticus 
RS-1 
Vibrio 3–5 × 1  
Bullet-shaped 
magnetite 
No growth No growth 
Mean length = 60 nm 
(32–85 nm) 12–15 NI [23,70] 
SF = 0.5 
Candidatus Desulfamplus 
magnetomortis BW-1 




No growth No growth 
Mean length = 55 nm 
NI NI [24,71] 
SF = 0.6 
AR = aspect ratio; NI = Not indicated (values are not present in the literature); SF = Shape factor. 
 




Magnetosomes are defined as intracellular organelles composed of magnetic iron mineral crystals 
individually surrounded by a phospholipid bilayer [27]. The size of the magnetic crystal usually varies 
from 35 to 120 nm between species. Within this size range, magnetic crystals are a single magnetic 
domain meaning that they have a permanent magnetic moment at ambient temperature [32]. They are 
usually organized in one or more chains within the cell, parallel to the axis of motility which, in most 
cases, is the long axis of the cell. The magnetic moment of the cell, in a magnetic field, imparts a torque 
to the cell, forcing it to realign along the direction of the applied field. In this way, magnetosomes work 
as a cellular magnetic compass [62]. The mineral portion of magnetosomes is composed of magnetite 
(Fe3O4) or greigite (Fe3S4) [72]. Both magnetite and greigite crystals share the same general morphologies: 
cuboctahedral (roughly cuboidal), elongated prismatic (rectangular in projection) or bullet-shape [2,62]. 
Chains of magnetosomes often lie next to or near the cytoplasmic membrane where they, in some cases, 
appear to be anchored. The number of chains and of magnetosomes in a chain varies from species to 
species (Figure 3) and in the same species, it often varies according to environmental conditions [33]. 
 
Figure 3. Transmission electron microscopy images of several different MTB showing their 
distinctive cell and magnetosome crystal compositions and morphologies. Scale  
bars = 500 nm in bacterial images and 100 nm in magnetosomes images. 
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The magnetosome membrane (MM) originates from an invagination of the cell membrane and is 
likely the first step in magnetosome biomineralization [73]. Different proteins are involved in this step 
and their recruitment changes the protein composition of the MM [27]. The following steps, that 
apparently occur simultaneously, are iron uptake, crystal nucleation, crystal maturation, and the 
alignment of magnetosomes into chains [74]. Iron is precipitated inside of the nascent vesicles to form 
magnetic crystals and, during the maturation of magnetosomes, most of these invaginations detach from 
the cell membrane and appear to become true vesicles [75]. 
Magnetosome biomineralization is a genetically controlled process that involves approximately  
28 proteins encoded by the so-called mam and mms genes. In Magnetospirillum gryphiswaldense,  
these genes are organized in four operons: the mamAB, mamGFDC, mamXY and mms6 operons [5,76].  
In Ms. gryphiswaldense, only the mamAB operon is essential for magnetosome synthesis while the 
absence of the other operons does not lead to the absence of magnetosomes but to differences in 
magnetite crystal morphology and the production of particles not clearly organized in chains [77].  
The operons, localized in a larger cluster in the genome of Ms. gryphiswaldense and of some other MTB, 
represent a genomic island referred to as the MAI standing for Magnetosome Island [76]. This genomic 
region contains genes responsible for iron transport, magnetite crystal nucleation and growth,  
magnetite crystal morphology, and magnetosome organization within the cell (Figure 4). Comparative 
studies based on cultured and uncultured magnetite- and greigite-producing MTB show that the 
mamABEIKMOPQ genes are strongly conserved among different species [73–77]. Although the function 
of many of these genes has not yet been elucidated, they have been inferred from similarities to other 
known proteins. One of the more conserved proteins is MamK, a homolog of the prokaryotic 
cytoskeleton protein MreB [78]. MamK is an actin-like protein that forms interconnected filaments along 
the cell. Magnetosomes are linked to this long structure by another protein called MamJ, although the 
gene coding for this protein is absent from the genomes of many MTB including Magnetovibrio blakemorei, 
Magnetofaba australis, and Magnetococcus marinus. In these bacteria, a hypothetical protein is encoded 
by a gene adjacent to mamK but it is not clear whether this protein functions similarly to MamJ. The 
fixed organization of magnetosomes into chains and its connection to the cell membrane enable the cells 
to orient along magnetic field lines since the torque exerted by magnetosomes chain is transferred to the 
whole cell [41]. 
Other proteins encoded by genes in the mamAB operon are thought to be related to the invagination 
process (mamB, E, I, L, and Q), to iron transport (mamB and M), and to magnetite biomineralization 
(mamE, O, T, P, and S) [73,79–81]. The mamXY operon encodes proteins related to the magnetosome 
membrane (mamY, X, Z, and ftsZ-like genes) and its deletion causes cells of Magnetospirillum to produce 
smaller magnetite particles with superparamagnetic characteristics [77,82]. Crystal size and shape are 
mainly regulated by proteins encoded in the mamCD operon (composed of the genes mamC, D, F, and G) 
and its deletion also leads to a reduction of the size of the magnetite magnetosome crystals [83]. The mms6 
operon contains five genes (mms6, mmsF, mgr4070, mgr4071, and mgr4074) [74] that also appear to be 
involved in magnetite crystal shape and size. The deletion of both the mamCD and mms6 operons 
seriously affects both the morphology of the magnetite magnetosome crystals and the alignment of the 
magnetosomes [83]. Recently, the entire set of magnetosome genes from Magnetospirillum 
gryphiswaldense were genetically introduced into Rhodospirillum rubrum, a non-magnetotactic 
photosynthetic bacterium causing it to express biomineralization of functional magnetite magnetosomes 
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structurally similar to those produced by Magnetospirillum and which conferred a magnetic moment to 
the host cell [40]. 
 
Figure 4. Proposed mechanism of magnetosome biomineralization in Magnetovibrio 
blakemorei strain MV-1. The putative magnetosome island (MAI) of Mv. blakemorei (A) [5] 
and the putative function of each encoded protein during magnetosome formation (B) based 
on their similarities to proteins described for Magnetospirillum species. The color of each 
ORF is used to identify the localization of encoded proteins. Unidentified genes in grey 
encode hypothetical proteins. The mamL, J, U, G, and F genes, although present in 
Magnetospirillum species, are not present in the MAI of Mv. blakemorei. 
Studies involving specific functions of magnetosome proteins (Table 2) have enabled the use of 
synthetic peptides that mimic the function of these proteins in the chemical synthesis of magnetite 
nanoparticles resulting in the synthesis of magnetite crystals with some of the desirable characteristics 
of magnetome crystals [84]. Knowing the localization of specific magnetosome proteins in the MM and 
their pattern of expression provide the opportunity to choose the best target for protein modifications, 
for example, gene fusions between a mam gene and a gene encoding a protein of catalytic interest [85]. 
Investigating proteins directly related to magnetosome crystal size and morphology remains an important 
but partially unexplored direction of research but being able to control these crystal characteristics will 
likely result in different physical and magnetic attributes for magnetosome specific applications. An 
excellent example of this is in hyperthermia treatment of tumors in which heat, generated by magnetite 
magnetosomes, even when the crystals have oxidized to the less magnetic mineral maghemite, subjected 
to an alternating magnetic field, is used to kill tumor cells. The amount of heat generated is dependent 
on magnetosome crystal size and morphology, and the distribution of particles inside the tumor further 
affects the efficacy of this treatment [86,87]. It has also been demonstrated that the size of magnetosome 
magnetite crystals affects their use as contrast agents in magnetic resonance imaging (MRI) [88]. 
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Table 2. Specific magnetosome proteins with their respective cell localization and putative functions in magnetite biomineralization by MTB. 






It has multiple domains with TPR motifs  
(protein-protein interactions); may act as multi-protein 
assembly site; stabilizes magnetosome chain. 
Invagination is not affected. Reduction  
in the number of magnetosomes and 








May be involved in iron transport since has 
homology to CDF (cation diffusion facilitator). 
Contains TPR domain (protein-protein interactions) 
and interacts with MamE; requires MamM  
for stabilization. 
Loss of magnetosome vesicles  







Its loop interacts with magnetosome crystal. It is 
not essential to biomineralization but may control 
chemical conditions inside vesicles. 
Changes in size and organization of 
chains and size of vesicles. No effects 








Associated with control over size of  
magnetosome crystal. 







Acts as a serine protease and has PDZ domain 
(protein-protein interaction) which interacts with 
MamB and I. Magnetochrome might control the 
magnetosome redox state and balance  
between Fe2+/Fe3+. 
Formation of empty magnetosome vesicles, 
loss of magnetite synthesis, mislocation of 
MamI and other Mam proteins. 
[74,80,89] 
MamF Transmembrane MM 
Crystal shape 
and size 
Associated to control of magnetosome size; 
interacts with crystal. 






Associated to control of magnetosome size. Changes in crystal size. [78,89] 
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Contains conserved domains homologous to MFS 
proteins (membrane transporters) and might 
function as phosphate transporter during 
magnetite biomineralization. 







Involved in the formation and bending  
of the MM. 




Acts as an anchor between MamK filaments and 
vesicle membrane to arrange magnetosomes in  
a chain. 
Magnetosomes arranged in clusters  






Controls chain assembly and position along the 
cell axis; positions chain for cellular division; 
homologous to MreB (actin-like). 
Lack of filaments near the magnetosomes. 







Involved in the formation of MM;  
similar to MamI. 







Involved in iron transport and may use H+/cation 
antiporter mechanism. Involved in the begining of 
crystalization and localization of other Mam 
proteins; stabilizes MamB; homologous to CDF 
(cation diffusion facilitator). 









Homologous to Na+/H+ antiporter and might be 
involved in the extrusion of H+ from the vesicle. 
Formation of empty magnetosome  
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Table 2. Cont. 
MamO 
Transmembrane  





Composed of two domains: (1) transmembrane, 
homologous to proteins involved in transport of 
anions across cell membrane and (2) similar to  
a trypsin-like peptidase, but possibly with no 
protease function. 
Formation of empty magnetosome vesicles. [74,89] 
MamP 
Transmembrane in 





Involved in control of crystal number and size and 
in electron transfer necessary to magnetosome 
assembly and magnetite formation; similar to 
MamE and MamT; may contain an  
iron-binding site. 
Defects in crystal size, fewer 




in MM; C-terminal 
in ML 
Invagination Unknown function; homologous to LemA. 






Controls the number and size of crystals; 
predicted to have a DNA-binding domain. 









Controls the number and size of crystals. 
Defects in crystal size and morphology, 









Involved in regulation of crystal size and 
morphology; has a magnetochrome domain. 
Defects in crystal maturation and loss of 
magnetotactic response. 
[74,89,95] 
MamU Cytosol Invagination 
Unknown function. Homologous to DGK Family, 
that includes kinase involved in regulation of  
cell response. 
None observed. [74,89] 
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Implicated it magnetite synthesis or not associated 
to magnetosomes. 
None observed. [76,77] 
MamX 
Transmembrane  





Involved in electron transport, with Cytochrome 
c-like domain; weak similarity to MamS and E. 
Smaller crystals and with irregular shapes. 




in MM; C-terminal 
in cytosol 
Invagination 
Constricts the MM and consequently affects 
crystal growth; homologous to BAR proteins 
(involved in membrane dynamics). 










Involved in redox control for magnetosome 
formation; creates an iron oxidoreductase and 
transport complex with MamX and MamH. 
Smaller size of crystals and higher 







Involved in the initiation of magnetite  
synthesis and control of crystal shape;  
presents in vitro activity. 
Smaller magnetosomes with heterogeneous 







Involved in the control of size and shape of 
magnetite crystal during maturation. 
Formation of elongated crystals and of  
non-magnetotactic cells. 
[74,89] 
BAR—Bin/Amphiphysin/Rvs domain related to membrane dynamics; CDF—cation diffusion facilitator; DGK—diacylglycerol kinases family; MM—magnetosome 
membrane; ML—magnetosome lumen; PDZ—conserved domain related to protein-protein interaction; MFS—major facilitator superfamily of secondary transporters;  
TPR—Tetratricopeptide repeat domain related to protein-protein interactions. 
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2.4. Mass Production of MTB and Magnetosomes 
Most studies aimed at large-scale production of magnetosomes have involved Magnetospirillum 
species and, therefore, most of the available information on magnetosome synthesis is based on strains 
of this genus. Magnetospirillum species produce cuboctahedral magnetite crystals about 40–45 nm in 
diameter. Each cell can possess up to approximately 60 magnetosomes organized as a single chain [98] 
although the actual number of magnetosomes per cell is clearly dependent on culture conditions. 
Magnetospirillum species are chemoorganoheterotrophic and use organic acids as source of carbon  
and electrons although autotrophy based on the oxidation of reduced sulfur compounds has been 
demonstrated in some strains [67]. Generally members of this genus grow microaerophilically or 
anaerobically, utilizing O2 and nitrate as electron acceptors, respectively, although one species,  
Ms. magnetotacticum, appears to require O2 even when respiring with nitrate [99]. Despite the fact  
that the magnetite oxygen originates from water, O2 concentration, as well as the presence of nitrogen 
oxides, are important factors that directly affect magnetite biomineralization in this genus [100].  
Microaerobic conditions are required for growth and production of magnetite in magnetosomes of  
Ms. magnetotacticum [38]. Despite the fact that cells grow in sealed flasks containing 0.1% to 21% oxygen 
in the headspace, concentrations higher than 5% inhibit magnetite magnetosome synthesis [31]. Iron 
uptake is also stimulated under microaerobic conditions [99]. The role of O2 in magnetite 
biomineralization is not clear, but the most accepted explanation is that it is required to establish optimal 
redox conditions for synthesis of magnetosomes and growth [101]. Moreover, Magnetospirillum species 
are relatively easy to grow especially compared to marine species of MTB, and have tractable genetic 
systems [40,99,102]. 
However, the recently described Magnetovibrio blakemorei utilizes a wider range of metabolic 
substrates, can grow and produce magnetosomes using a wider range of electron acceptors [17] and is 
amenable to mass cultivation in large scale [39]. Thus, this species is an excellent candidate for the mass 
production of magnetosomes. Moreover, cells of Mv. blakemorei produce elongated prismatic crystals 
of magnetite, a characteristic that results in a particle with a stronger magnetic anisotropy thereby 
facilitating their manipulation by external magnetic fields [87]. These magnetosome crystals also have 
a larger surface-to-volume ratio than the cuboctahedral crystals of Magnetospirillum [103],  
a characteristic of special interest for applications involving adhesion or the expression of proteins in  
the MM, since it provides a larger surface area for substrate binding. Most applications require that 
magnetic nanoparticles have a controllable, consistent magnetic anisotropy and, therefore, that they have 
a defined and preferentially elongated shape [87]. It has been demonstrated that magnetosome vesicles 
in Mv. blakemorei are elongated prior to magnetite crystal formation suggesting that they predefine 
crystal morphology at least in this species [103]. Although the gene for MamK filaments was detected 
in the genome of Mv. blakemorei, cryomicroscopy images of frozen cells revealed only fragmented 
filaments that were not attached to magnetosome vesicles or to the poles of the cell (Figure 4). Moreover, 
magnetosome vesicles directly connected to the cell membrane were not found suggesting that they 
detach shortly after invagination [103]. These features indicate that magnetosome formation in  
Mv. blakemorei differs from that described for Magnetospirillum species although it is clear that genetic 
studies are required to clarify this process. Such studies are currently difficult to perform because of a 
lack of a reproducible genetic system in Mv. blakemorei. 
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To obtain high yields of magnetite magnetosomes from Magnetospirillum species, cells are  
generally grown in a bioreactor chemoorganoheterotrophically with O2 as the terminal electron acceptor, 
succinate or lactate as the electron and carbon source, and nitrate or ammonium ions as the nitrogen 
source [38,104,105]. Since magnetosome formation is higher under microaerobic conditions [101], the 
main drawback to mass culture is the need to maintain strict control over the dissolved O2 concentration 
in the growth medium. There are a number of published studies, most using Magnetospirillum species 
as the model MTB, involving comparisons of growth media and the optimization of growth conditions 
for maximum magnetosome yields by MTB. Growth and magnetosome production was compared 
between Ms. magneticum, Ms. magnetotacticum and Ms. gryphiswaldense all grown in a 5 L bioreactor 
under the same conditions [38]. Ms. gryphiswaldense had the highest growth rate and showed the highest 
tolerance to O2 [38]. Although growth of Ms. gryphiswaldense was not impaired by variations in O2 
concentration, iron uptake and the cellular magnetotactic response was reduced by half with increasing O2 
concentrations [38]. The maximum magnetosome yield was of 6.3 mg magnetite L−1·day−1 by  
Ms. gryphiswaldense and 3.3 mg and 2.0 mg for Ms. magneticum and Ms. magnetotacticum, 
respectively, when these cells were cultured under a constant O2 tension of 0.25 mbar and a growth 
medium containing lactate as the carbon source and ferric citrate as the iron source (Table 3) [38]. 
Although the methods used to estimate magnetosome productivity varies greatly, the values presented 
here are comparable to those achieved in cultures of Magnetovibrio blakemorei: 4.98 mg  
magnetite L−1 day−1 prior to optimization of the growth medium [39]. The utilization of iron-chelating 
agents such as hemoglobin (0.4 µM) and EDTA (ethylenediamine tetraacetic acid at 4 µM) in the growth 
medium resulted in up to a 6-fold increase in crystal production by Ms. magneticum cells. Moreover, the 
chains produced in the presence of iron-chelating agents were longer and with improved heating 
capacities when subjected to an alternating magnetic field [106]. These experiments were carried out in 
10 or 500 mL flasks and a rationale of cost to benefit is necessary for the utilization of chelating agents 
in large-scale cultures. 
Table 3. Magnetite production by MTB in large scale mass cultures. 
MTB Culture Medium 
Magnetite 
production 
(mg L−1) * 
Magnetite 
productivity  
(mg L−1 day−1) * 
References 
Ms. magneticum Fed-Batch MSGM 9 ± 0.7 3.7 ± 0.13 [104] 
Ms. gryphiswaldense Batch LSM 7.9 6.3 [38] 
Ms. gryphiswaldense NPHB Fed-Batch OFM 58.4 ± 6.4 - [107] 
Ms. gryphiswaldense Fed-Batch OFM 41.7 16.7 [105] 
Ms. gryphiswaldense Fed-Batch OFM 83.23 ± 5.36 55.49 [108] 
Ms. gryphiswaldense Fed-Batch OFM 356.52 178.26 [109] 
Ms. gryphiswaldense Semi-continuous OFM 168.3 83.5 [109] 
Mv. blakemorei Batch-flask [17] 15.14 4.98 [39] 
Mv. blakemorei Batch-flask Optimized 64.35 16.09 [39] 
Mv. blakemorei Batch Optimized 22.4 5.6 [39] 
Mv. blakemorei Fed-Batch Optimized 26 3.2 [39] 
MSGM: Magnetic Spirillum Growth Medium [13]; LSM: Large Scale Medium [35]; OFM: Optmized Flask 
Medium [94]. * Estimates of magnetite production and their error bars (when present) are given as reported in 
reference articles. 
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Magnetospirillum gryphiswaldense was cultured in a 42 L fed-batch bioreactor in which the 
concentrations of lactate as carbon source and O2 were rigorously controlled [108]. The strategy was to 
stimulate growth by initially increasing the O2 concentration to a relatively high level and then allowing 
bacterial respiration to reduce partial pressure of O2 to levels optimal for magnetosome magnetite 
synthesis and repeating this cycle by introducing more O2 and increasing the speed of stirring [108]. This 
methodology was used to satisfy the culture’s different requirements for O2 for growth and also for 
magnetosome production while later maintaining the dissolved O2 concentration at a threshold for both. 
This resulted in a magnetite yield of 16.7 mg magnetite L−1 day−1. Magnetosome production by  
Ms. gryphiswaldense increased with further adjustments of the stirring rate and air flow to the culture to 
control the dissolved O2 at an optimal level for magnetite synthesis and the pH-stat feeding of nutrients 
to maintain the concentrations of ferric citrate and lactate between 70–110 mM and 3–6 mM, 
respectively (Table 3) [108]. 
Modifications to the growth medium and incubation conditions have been used by many different 
research groups with the goal of maximizing growth and magnetosome production at minimum expense. 
For example, the constant input of sodium lactate and NH4Cl in the fed-batch strategy resulted in the 
accumulation of Na+ and Cl− ions which increased the osmotic potential of the medium negatively 
affecting the growth of Ms. gryphiswaldense [109]. The substitution of carbon and nitrogen sources for 
lactate and NH3, respectively, in the feed solution led to an increase in cell growth and magnetosome 
production in a bioreactor of 42 L [109]. Growth and magnetosome production can also be increased by 
employing a semi-continuous culture strategy. In a 7.5 L bioreactor, the first stage of semi-continuous 
culture of Ms. gryphiswaldense was maintained until late exponential growth (40 h) with a magnetosome 
production of 168.29 mg L−1 day−1 and then 10% of the volume of this culture was used to inoculate the 
second stage of the culture which reached a magnetosome yield of 83.54 mg L−1 day−1 after 28 h  
(Table 3) [109]. 
Optimization of the growth medium of Magnetovibrio blakemorei led to a magnetosome yield of  
22.4 mg L−1 after 96 h when cells were grown in a 2 L bioreactor. Further pulses of iron injected in the 
bioreactor increased magnetosome production to 26 mg L−1 although magnetosome synthesis then 
decreased after relatively long incubation times (e.g., 196 h) [39] (Table 3). 
Differences observed in magnetosome production and magnetite productivity by different MTB 
(Table 3) are certainly due to the different strain characteristics and culture conditions. However, the 
methodologies utilized to estimate magnetite production by each strain is often difficult to compare 
directly in these studies. Measurements of magnetite production have been determined by counting the 
number of cells and the number and size of magnetosomes per cell, thereby allowing for the calculation 
of the number of magnetosomes per mL [39]. Estimates based on extracted magnetosomes using 
spectrophotometry [107] have also been reported but in many studies the way magnetosome production 
is estimated is not clear. 
Optimization of the growth medium for Magnetovibrio blakemorei was recently achieved using a 
statistics-based experimental design which involved the removal of some components and an increase 
in the concentration of others [39]. In this study, we evaluated the relationship between the cost of the 
initial and optimized culture media in relation to culture productivity (cell yield) and estimated the cost 
of each medium component before and after optimization (Figure 5). The increased amount of sodium 
succinate as the carbon source raised the cost substantially while the elimination of certain components, 
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such as the vitamin solution, reduced the cost of the medium and was pivotal to balancing the cost and 
production in this case. Nevertheless, optimization of the growth medium resulted in an increase in the 
overall cost by a factor of 2 (from $2.50 to $5.04 USD per L) while magnetosome production increased 
by 8-fold, resulting in a four-fold net increased production. 
 
Figure 5. Comparative analysis of the cost of each growth medium component as a 
percentage of the initial and optimized media for Magnetovibrio blakemorei. Medium 
components have been described previously [36]. 
Besides modifications in growth media and culture conditions, magnetosome productivity can be 
modified through genetic manipulation of the magnetotactic strain used. For example, a mutant strain of 
Magnetospirillum gryphiswaldense with a higher O2 consumption rate during growth and a lower 
accumulation of intracellular granules of poly-ß-hydroxybutyrate (PHB) produced more magnetosomes 
than the wild-type strain under the same culture conditions [107]. On the other hand, magnetosome 
production decreased in cultures of a mutant of this same organism that produces higher amounts of 
PHB granules (compared to the wild-type) grown in a bioreactor [107]. Genetic engineering of MTB is 
also of premier importance when the goal is to modify the expression of specific magnetosome proteins 
in the MM. This strategy of modifying the MM through genetics offers advantages in comparison to 
chemical functionalization, such as the correct positioning of the expressed proteins where the catalytic 
site (if present) is exposed to the appropriate substrates thereby preserving the catalytic activity of 
purified enzymes. This is significant since chemical immobilization procedures involving proteins could 
lead to loss of enzyme activity [85]. 
After magnetosome production, it is necessary to separate and purify magnetosomes or magnetosome 
crystals for use in the majority of biotechnological applications. Magnetosomes have been successfully 
purified from cells of MTB using a number of different procedures. Harvested cells of MTB must be 
first lysed prior to magnetosome purification. After cell lysis, magnetosomes can be separated from cell 
debris and non-lysed cells by exploiting their magnetic properties using relatively strong magnets. Cell 
disruption can be achieved by ultrasonication, alkaline lysis, and by use of a French press or a  
high-pressure homogenizer [107–109]. Importantly, the MM lipid bilayer is maintained as a coherent 
structure around the magnetite crystals with all these techniques [107–109]. Removal of the lipid 
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membrane is possible with the use of detergents such as sodium dodecyl sulfate (SDS), allowing for the 
purification of the magnetosome magnetite crystals which tend to agglomerate due to the magnetotactic 
interactions between particles after detergent treatment [110]. Extensive washing of magnetosome or 
magnetosome crystals after separation is crucial to obtain clean material suitable for further use since 
cell debris (e.g., membranes) including electrostatically-charged cell proteins that might associate with 
the MM but are not part of it, are difficult to remove and could interfere with the performance of 
magnetosomes in specific applications (Figure 6). 
 
Figure 6. Magnetosomes purified from cells of Magnetovibrio blakemorei strain MV-1. 
Magnetosomes purified from cells lysed using physical methods or alkaline lysis (A) with 
the magnetosome membrane (MM) shown in the inset (at arrows). Note that after this 
treatment most magnetosomes remain in chains (at arrowhead in A); Some physical-chemical 
methods lead to magnetosomes losing their membranes and arrangement, forming clumps 
due to magnetic interactions between magnetosome crystals (B). Cell debris (arrowheads in B) 
is generally always present in poorly washed suspensions of magnetosomes reducing purity 
of the preparation and potentially interfering with specific applications of the isolated 
magnetosomes. Scale bars = 1 μm in A (100 nm in inset), 150 nm in B. 
Advances made in the mass culture of MTB and the mass production of magnetosomes and the 
general need for large amounts of material for specific applications has led to the development of 
continuous magnetosome purification procedures at large scale. These techniques involve the lysis of 
large quantities of cells, which are disrupted using a high-pressure homogenizer, followed by separation 
of magnetosomes from cell debris by passing the lysate through a magnetic column composed of a 
material that is strongly magnetic when placed in a very high strength magnetic field. Magnetosomes 
remain in the column and can be washed repeatedly as other materials pass through the column. 
Magnetosomes are recovered from the column by removing the external magnetic field and  
passing buffer or water to wash out the magnetosomes. Further treatment of magnetosomes to  
remove surface proteins and cell DNA is carried through low-power sonication and the use of urea and 
proteinase K [111]. This process is important for in vivo applications of nanosized magnetite particles, 
such as drug delivery, where strict standards of purification are required to avoid toxicity and 
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immunological responses to the MM and extraneous proteins [112]. For biotechnological applications 
where it is necessary to preserve the MM and the surface proteins of functionalized magnetosomes, 
treatment of the magnetosomes with urea and proteinase K can be eliminated. Alternatively cells could 
be lysed using a French pressure cell for cell disruption followed by magnetosome purification as 
described above. The use of either procedure preserves the activity of magnetosomes functionalized with 
luciferase-MagA [113], other GFP-fusion proteins, and enzymes [85,114]. These processes can be used 
to isolate non-modified magnetosomes that can be lyophilized and/or sterilized by γ-rays and stored for 
further use. These isolated magnetosomes have low toxicity to different kinds of mammalian and human 
cells including H22, HL60, EMT-6 cells or mouse fibroblasts, and to live mice [112,115]. 
2.5. Biotechnological Applications of Magnetosomes 
Nanometer-sized magnetic particles are of great interest in biotechnology since they have a large 
surface area which can be used for anchoring relatively large amounts of specific molecules and can be 
easily manipulated using an external magnetic field. These magnetic particles including magnetosomes 
can be bound to proteins, cells, viruses, or genes of interest which can be then be subsequently separated 
using magnetic techniques [116]. The particles most often used for these types of studies consist of iron 
oxides especially magnetite and maghemite (γ-Fe2O3) which are more stable than iron sulfides such as 
greigite. They have been used in various biomedical applications such as immunoassays, cell separation, 
hyperthermia protocols (treatment of cancer by localized heating), drug carriers, nuclear magnetic 
resonance, and others [117]. These applications require that the magnetic particles have high 
magnetization, consistent sizes smaller than 100 nm, consistent morphologies, and are biocompatible 
(are non-toxic). Nanoparticles of magnetite can be synthesized abiotically using various processes such 
as co-precipitation [118], microemulsion [119], electrochemical synthesis [120], hydrothermal  
synthesis [121], oxidation-precipitation [122], and others. However, these chemically-produced 
magnetites generally do not have all the desirable features necessary for certain applications but are 
characteristic of bacterial magnetosomes. 
Magnetosome magnetite crystals have high magnetization, consistent species-specific nanometer 
sizes and morphologies, and based on a number of recent studies, appear to be biological  
compatible [41]. Their narrow, single magnetic domain size distribution is difficult to achieve using 
chemical synthesis techniques [87]. This characteristic, their excellent degree of crystallinity, and 
anisotropy are advantageous particularly in applications in which thermal stability and hysteretic heating 
are required such as in hyperthermia treatments [87]. Specifically in hyperthermia, it has been shown 
that magnetosomes are advantageous in relation to synthetic nanoparticles because their organization in 
chains favors their internalization by cells and permits magnetosomes to be homogeneously distributed 
inside the tumor, a factor that increases the effectiveness of the treatment in killing tumor cells [123]. In 
addition, because of the MM, magnetosomes can be functionalized either chemically, which involves 
chemically attaching specific proteins (e.g., antibodies) or other molecules, or by genetic engineering in 
which genes encoding proteins of interest are fused to specific magnetosome genes encoding MM 
protein components [85]. How this coupling is made is important because it can affect the stability and 
quantity of these molecules bound to each magnetosome and thus directly affect efficacy of the modified 
magnetosome in specific applications [124]. The amine groups located in the MM have been used for 
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the immobilization of functional molecules. Different molecules can be bound to the amine groups on 
the MM and further, antibodies can be bound to these molecules [125]. Glutaraldehyde has been 
successfully used to directly link an antibody to magnetosomes [126] while several antimicrobial 
peptides were tested for their spontaneous integration into the MM [127]. 
The surface of the magnetosomes can be modified for use in DNA extraction procedures. These 
modifications include organic compounds which create an amine layer forming a cover with a positive 
ionic charge that facilitates the interaction between DNA molecules and magnetosomes, leading to a 
much higher efficiency in the recovery of DNA than other available magnetic particles kits [128]. 
Several techniques were developed to express and efficiently display functional molecules attached to 
the MM. Some MM proteins have their catalytic sites exposed. Genes encoding these MM proteins can 
be fused to genes encoding proteins of interest, resulting in the correct positioning of the catalytic site 
on the surface of magnetosomes. Ideally, the anchor protein should be highly expressed to increase the 
amount of the exposed catalytic site. An excellent example of a MM anchor protein appears to be the 
MamC protein of Magnetospirillum magneticum which is highly expressed in MM and has been used 
effectively as an anchor display different enzyme complexes [85,114,129]. Other MM proteins including 
MagA and Mms6 have been used to anchor protein A, luciferase, and an estrogen receptor [130,131]. 
Mass scale production of modified magnetosomes was assayed in a 10 L bioreactor under 
microaerophilic conditions with pH-stat feeding of carbon and nitrogen sources. Ms. magneticum 
carrying a plasmid with a fused protein Mag-luciferase was grown and the production of modified 
magnetosomes was enhanced with addition of cysteine, yeast extract, peptone and ferrous sulfate  
as iron source. The plasmid inserted for production of the fused protein was stable under these  
non-selective conditions [130]. 
The model of magnetosome synthesis has been utilized in producing chemically-synthesized, 
bioinspired magnetic nanoparticles by precipitating magnetite chemically in the presence of various 
purified magnetosome proteins including mms6 [84]; this strategy helps to overcome some costs 
associated with the growth of MTB and the purification of magnetosome crystals for specific 
applications [84]. Numerous applications of nanosized magnetic particles have recently been  
reviewed [58,63]. Again, given the high costs involved in the culturing of MTB and magnetosome 
purification, in large scale for the production of magnetosomes, it seems likely that magnetosomes will 
only be useful in situations where it makes economic sense such as in biomedical procedures where the 
high purity of the crystals, low toxicity, and high biocompatibility may be absolutely necessary. 
Living and motile MTB have proven useful in bioremediation, cell separation, as carriers of specific 
molecules, and in the detection of magnetic domains in hard materials. The detection of magnetic  
fields emitted by different materials, such as rocks and meteorites, can be identified nondestructively 
with the use of living MTB, since cells swim towards magnetic poles along the direction of the magnetic 
field [132]. Living MTB interact with different molecules by taking them up within the cell or binding 
them on the cell wall surface. In this way, they have been shown to have potential in the bioremediation 
and removal of plutonium radionucleotides and heavy metals [133]. A system was created to allow the 
interaction of MTB with a solution contaminated with plutonium and subsequently the cells were 
separated by magnetic orientation thereby recovering the plutonium [134]. Desulfovibrio magneticus 
was used in the recovery of cadmium present in the growth medium [135]. Cells of Magnetospirillum 
gryphiswaldense reduced gold ions to gold nanoparticles that became attached to the bacterial surface 
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and could then be separated using magnetic techniques [136]. Viable granulocytes and monocytes after 
phagocytizing living cells of MTB can be magnetically purified from blood [137]. Finally, although it is 
unlikely that regulatory agencies would approve treatments involving the application of living bacteria 
in the blood stream, it has been shown that MTB have great potential for acting as drugs carriers in the 
human body. Cells of Magnetococcus marinus can carry fluorescent microbeads of 2 µm and swim at 
their normal speed along magnetic field lines [138]. Cells might therefore be able to efficiently navigate 
under simulated conditions imitating the interior of the human body. Theoretically, they could be 
targeted to a specific part of the human body, carrying various types of molecules/drugs and are small 
enough not to interfere with blood flow. Finally, cells of Mc. marinus can be detected and monitored by 
MRI because of changes in the magnetic field caused by magnetosomes [139]. 
Isolated magnetosomes, especially when functionalized with proteins or antibodies, have an even 
broader range of applications than intact living or dead cells of MTB, including bioremediation, 
separation of molecules, drug carriage, gene therapy, and cancer treatments. As stated above, isolated 
magnetosomes can be highly purified and sterilized. Therefore, biomedical applications using 
magnetosomes are likely safer when used in living cells or organisms. Many potential medical and 
environmental applications of isolated magnetosomes have been examined. Ginet et al. (2011) [85] 
showed that the magnetosomes can be used as reusable biocatalysts. When functionalized with the 
enzyme phosphohydrolase, they can be used to degrade certain pesticides since the catalytic function of 
the enzyme after expression in the surface of the magnetosome membrane is preserved. These modified 
magnetosomes can be recycled and the catalytic activity of the phosphohydrolase, in one study, remained 
stable after repeated cycles of degradation of the pesticide [85]. Isolated magnetosomes from MTB 
genetically modified to express a multi-subunit enzyme complex of a chimeric RNaseP in magnetosomes 
showed full RNaseP activity [129]. Magnetosomes functionalized with the enzyme PPDK (pyruvate 
phosphate dikinase) proved usful in pyrosequencing. The magnetosome-enzyme display system could 
also be recycled without major loss of enzyme activity and magnetic separation allowed for a rapid 
buffer exchange, stringent washing, and reduced non-specific binding. These features reduced costs and 
improved the analytical process [140]. 
The identification of minimal quantities of targeted molecules can be determined using  
Immuno-PCR technology. In this case, the targeted molecule is recognized by antibodies and then 
marked with DNA for RT-PCR. A variant of this assay with antibody-functionalized magnetosome 
(MagnetoImmuno-PCR) allows immobilization of the targeted molecule and its magnetic separation. 
This technique can be used independently from solid phase materials and retain all the advantages from 
standard Immuno-PCR [141]. Matsunaga and collaborators (2007) built complexes of magnetosome 
with polystyrene microbeads that provided a larger interaction surface. The complexes were more 
efficient than the magnetosomes alone when applied to automated immunoassay for the detection of 
human prostate-specific antigen (PSA) [142]. Magnetosomes conjugated with antibodies consist of a 
sensitive tool for magnetic separation and specific screening of target cells. Magnetosomes remain 
connected when the cells are placed again in culture and do not appear to interfere with growth and 
differentiation. In addition, the magnetosomes do not interfere with spectrophotometric measurements 
which can be a problem when artificial magnetic particles are used [143]. Magnetosomes have been used 
as markers of biomolecular interactions using magnetic force microscopy (MFM). For example, 
streptavidin molecules, immobilized on a slide, bind to magnetosomes conjugated with biotin which can 
Mar. Drugs 2015, 13 413 
 
 
be identified using MFM, resulting in an assay that is 100 times more sensitive than the streptavidin 
detection with fluorescence [144]. 
Magnetosomes have been used as carriers of specific molecules in many studies. It has been shown 
that magnetite magnetosomes attach to a larger amount of drug molecules in cancer chemotherapy  
than artificial, chemically-synthesized magnetite particles and provide more control over the drug  
release [145]. A good example of this is the drug doxorubicin [112]. Magnetosomes injected into the tail 
vein of nude mice localized mainly in the liver and lungs but not in other organs. They could be detected 
even after 2 weeks and, therefore, suggesting that they can be used to deliver drugs specifically to these 
organs [146]. 
Magnetosomes have also been used as carriers of recombinant DNA to produce a genetic vaccine for 
the immunotherapy of tumors. Treated tumors showed a significant reduction and no apparent toxicity 
to the vaccinated mice. Moreover, magnetosomes showed no immunogenicity: an immune response was 
induced only by pieces of DNA bound to the magnetosome demonstrating that magnetosomes have great 
promise as carriers for technologies involving gene therapy and genetic immunization [147]. 
Magnetosome cytotoxicity is apparently low as the viability of cells incubated with magnetosomes after 
72 h was 90%. The MM of the magnetosome seems to provide better biocompatibility than synthetic 
magnetite [148]. 
Magnetosomes can also be used directly for cancer treatment using hyperthermia therapy. 
Magnetosomes placed in tumor tissues are exposed to an external, alternating magnetic field  
thereby releasing heat that theoretically kills tumor cells and thus eliminates or decreases the size of  
the tumor [37]. It is noteworthy that chains of magnetosomes were more effective in killing tumor cells 
in comparison to individualized magnetosomes. The acute toxicity of magnetosomes injected into rats 
appears to be low but further studies accessing the risk-benefit of this treatment are necessary [86]. 
Where magnetosomes accumulate after being injected into the bloodstream of an organism is  
still a matter of debate. Little data is available and they indicate magnetite magnetosomes and 
chemically-synthesized magnetite particles differ in their destination in the organism [123]. Some 
magnetosomes administered to mice were found in lysosomes of their liver and spleen suggesting that 
macrophages remove magnetic particles from the bloodstream and carry the magnetosomes to these 
organs [149,150]. Particles in these lysosomes were partly digested and no particles were found in the 
faeces or urine of those animals [149] although there is one report of magnetosomes being eliminated 
from mice via feces [86]. Additional studies are clearly warranted to determine the distribution and 
elimination of magnetosomes in organisms treated with these particles. 
As new strains of MTB are isolated, more of their genomes become available, the functions of more 
magnetosome proteins are elucidated, and new molecular techniques are developed, it is likely that the 
numbers of commercial, scientific, and biomedical applications of magnetosomes and bioinspired 
magnetic nanoparticles will increase and become more widespread especially as economically viable 
strategies emerge for the production of these structures. Applications of magnetosomes as drug carriers, 
as contrasting agents or in cancer therapy clearly will require regulation of the US Food and Drug 
Administration (FDA) and other similar agencies. Two main aspects must be addressed in order to 
achieve FDA requirements: the Guidelines for Manufacturing Practices (GMP) and tests for the  
toxicity or side effects of the treatment, such as Limulus Amoebocyte Lysate (LAL) tests applied for 
other drugs [151]. Although a specific guideline for the use of magnetosomes in medical treatments does 
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not exist yet, it may be possible that the guidelines for the approval of chemically-synthesized magnetic 
particles for use as contrasting agents in MRI and in cell separation assays [152] could be applied to 
isolated magnetosomes. 
3. Genomic Studies on MTB as Potential Sources for New (Natural) Products 
The increasing availability of complete and incomplete genome sequences of MTB has greatly 
improved the culturing of these fastidious microorganisms by providing information of their metabolic 
capabilities and of their nutritional requirements [153]. Genomic data, in general, has helped to 
determine an organism’s metabolism by revealing which genes are present and may be involved in 
specific biochemical pathways. This cannot always be determined in laboratory growth experiments. 
Thus genomic information is also helpful for elucidating appropriate substrates for growth and/or 
optimization of growth media that will support the isolation and maintenance of new strains [6,154] and 
enhance the expression of genes coding for bioproducts of interest. 
We have used a genome mining strategy in marine MTB to detect genes encoding secondary 
metabolites and other bioproducts that might be able to be co-produced in bioreactors once the proper 
conditions for optimal gene expression are determined. We applied the antiSMASH platform [155], 
which searches whole genomes or contigs for conserved domains in gene clusters coding for natural 
product biosynthesis. This platform uses profile Hidden Markov Models (pHMMs) to search query 
protein-encoding genes for signatures or protein domains that have been experimentally accessed. 
Homologies are further investigated with implemented ClusterBlast analyses that consider as  
match those with a minimum specified value (e-value < 1E-05; 30% minimal sequence identity and 
coverage >25%) [155]. Secondary metabolites comprise an important class of pharmaceutically active 
compounds that includes antibiotics, antiparasitics, immunosuppressants, and anti-cancer drugs. Most 
of these types of metabolites have been found to be produced by species of the Domain Bacteria and  
the Kingdom Fungi isolated from different environments [156]. Strains of the prokaryotic genus 
Streptomyces have been regarded as the greatest source of these types of active compounds but recent 
genome studies have revealed that many species, including anaerobic prokaryotes, contain clusters of 
genes involved in secondary metabolite synthesis [156,157]. The main pathways for the synthesis of 
those compounds are the nonribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) 
pathways. Three classes of PKS systems exist and, although their mechanism of function differs slightly, 
they are involved in the production of a variety of complex molecular structures by the oligomerization 
of simpler molecules [158]. PKS I is the most studied class and consists of large proteins containing 
different active domains that include acyltransferases, acyl-carrier proteins, dehydratases, ketosynthases 
and ketoreductases. NRPS systems are also divided into enzymatic domains such as adenylation, 
thiolation, condensation, epimerization, methylation, reduction, and cyclisation [158]. This system 
selects and modifies amino acids to generate molecules of interest [156]. Both pathways can be expressed 
together and generate PKS-NRPS hybrid products, enhancing the diversity of bioactive compounds 
produced through these systems [158]. 
As discussed in an earlier section, all known MTB from aquatic environments, ranging from brackish 
to hypersaline, phylogenetically belong to the phylum Proteobacteria while some freshwater strains 
belong to the Nitrospirae phylum and PVC superphylum as well as the Proteobacteria. PKS and NRPS 
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domains have been found in both aerobic and anaerobic members of the Proteobacteria [156,157] but, 
to our knowledge, the presence of these domains has never been investigated in MTB. There are 
currently seven completely sequenced genomes of MTB publicly available including that from: the 
marine strains Magnetococcus marinus [57], Magnetospira sp. QH-2 [56] and Candidatus 
Magnetoglobus multicellularis [153]; the freshwater sulfate-reducing bacterium Desulfovibrio 
magneticus [159] and Magnetospirillum magneticum strain AMB-1 [160], Ms. gryphiswaldense strain 
MSR-1 [161] and Magnetospirillum sp. strain SO-1 [162]. Other genomic data discussed in this work 
are from MTB genomes currently under assembly or annotation and have not been published yet. In our 
analyses (Table 4), we found clusters of genes with conserved domains from PKS and NRPS in MTB 
which might represent a yet unexplored source for new bio-compounds. 
With regard to the cultured magnetococci, we did not detect PKS or NRPS domains in the genome of 
Magnetococcus marinus as previously reported [57] and found only three ORFs (open reading frames) 
containing PKS-NRPS domains in the genome of Magnetofaba australis. These were organized as a 
unique gene cluster flanked by transposase genes typical of a genomic island [163]. All ORFs presented 
higher similarity to genes sequenced from the Gram-positive, spore-forming bacterium Paenibacillus 
curdlanolyticus (identity ranging from 40% to 51%, coverage from 89% to 99%) and a much higher GC 
content (63.71% to 68.60%) than the rest of the Mf. australis genome (57.98%) indicating that they were 
probably transferred horizontally to the magnetotactic strain. Therefore, we do not believe that the 
cultured magnetotactic cocci would be good candidates for searches involving the production of novel 
secondary metabolites. The same applies to the marine spirillum Magnetospira strain QH-2, whose 
genome appears to contain only two ORFs containing NRPS domains, both with low similarity to amino 
acid adenylation enzymes from cyanobacteria (identity 40%, coverage 87%). 
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Table 4. Number of ORFs containing polyketide synthase (PKS) and/or nonribosomal peptide synthetase (NRPS) conserved domains in 
analyzed magnetotactic genomes. 
Species Strain Class † Source Salinity Genome (Mb)/MAI (Kb) PKS NRPS Hybrid 
Mc. marinus MC-1 α Pettaquamscutt Estuary—USA Brackish to marine 4.71/55.82 0 0 0 
Mf. Itaipuensis * IT-1 α Itaipu lagoon—Brazil Brackish to marine 4.98/64.9 3 0 0 
Mv. blakemorei MV-1 α Saltmarsh pool—USA Brackish 3.70/66.03 6 0 1 
Magnetospira sp. QH-2 α Intertidal seawater—China Saline 4.0/45 0 2 0 
Ms. gryphiswaldense MSR-1 α Eutrophic river—Germany Freshwater 4.36 + 0.036/74.6 3 0 2 
Magnetospirillum sp. * SO-1 α River—Russia Freshwater 4.87/100 0 0 1 
Ms. magneticum AMB-1 α Koganei ponds—Japan Freshwater 4.97/73 0 0 1 
Order Chromatiales SS-5 γ Salton Sea—USA Hypersaline 3.7/ND 1 3 5 
Ca. Da. Magnetomortis * BW-1 δ Badwater Basin—USA Brackish 6.8/ND 8 4  3 
Ca. Mg. multicellularis * MMP δ Araruama Lagoon—Brazil Hypersaline 12.8/15.7 9 11 4 
Desulfovibrio magneticus RS-1 δ Kameno River—Japan Freshwater 5.25 + 0.058 + 0.008/71 0 0 0 
† All marine strains of magnetotactic bacteria belong to phylum Proteobacteria. * Genome assembly of these species is not complete and the number of ORFs (Open Reading 
Frames) might be reduced in the final analysis. 
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In contrast, the genomes of the unnamed gammaproteobacterial strains SS-5 and BW-1 contain a 
relatively large number of PKS and/or NRPS domain-containing ORFs, 9 and 15, respectively (Table 4). 
However, these genomes are not completely assembled and therefore the number of ORFs may be 
slightly reduced or increased and the arrangement of gene clusters and genes within clusters might  
differ in the final assembly. In the genome of Candidatus Desulfamplus magnetomortis strain BW-1,  
we discovered a 4210 amino acid ORF with PKS domains similar to genes found in members of the 
family Desulfobacteraceae (coverage 96%, identity 62%), the family most closely related phylogenetically 
to strain BW-1. Another gene cluster is present that contains 12 ORFs with hybrid domains that show 
low similarity to genes encoding proteins with PKS and NRPS domains (coverage ranging from 85% 
with identity of 39% to coverage of 84% and identity of 62%) although no specific biosynthetic pathway 
could be assigned to them. The larger ORF in strain SS-5 (7595 amino acids) indicates some similarity 
to putative PKS-NRPS proteins from Streptomyces species (identity 38%, coverage 90%). In another 
gene cluster, a 5128 amino acid ORF best matched the ttcB gene from the marine Thalassospira sp. 
(identity 44%, coverage 99%), which is involved in the synthesis of thalassospiramide, a compound with 
immunosuppressant activity [164]. A third gene cluster contains an ORF with NRPS domains most 
similar to the nosD gene (identity 39%, coverage 95%), part of the nostopeptolide gene cluster originally 
discovered in the cyanobacterium Nostoc sp. [165]. Two other ORFs in a fourth cluster (2163 and  
1321 amino acids long) were also similar to genes encountered in cyanobacteria (coverage 98%, identity 
29%; coverage 99%, identity 38%, respectively). The low level of similarity between genes containing 
PKS-NRPS and characterized proteins denotes the importance of the search for conserved sites in these 
multi-domain proteins [157]. The putative function of these proteins remains unknown given their low 
similarities to described proteins; however, the search for conserved domains in a cluster of ORFs 
permitted their assignment to secondary metabolite pathways. The differences between the described 
proteins and the new ORFs analyzed in this work represent the potential of new bioactive molecules 
produced by MTB and reinforce the need of further studies to characterize their expression, especially 
in new organisms in which secondary metabolite pathways remain unexplored. 
The genome of the freshwater magnetotactic bacterium Magnetospirllum magneticum contains a 
single ORF containing hybrid domains, whereas five ORFs with PKS and NRPS domains were detected 
in Ms. gryphiswaldense, suggesting that modification of the growth medium or culture conditions for 
the later bacterium might provide the necessary environment and substrates for the enhanced expression 
of genes encoding secondary metabolites. Although searches in the genomes of the deltaproteobacterial 
MTB strains are not conclusive because most of the genomes available are not closed, the relatively high 
amount of secondary metabolite gene domains found suggests these organisms might have a relatively 
complex metabolism as previously indicated by culture and genomic studies [24,153]. MTB of the 
Deltaproteobacteria class have unique features in comparison to other MTB. This is the only class in 
which greigite synthesis was detected in MTB and includes all forms of the multicellular MTB and 
strains capable of biomineralizing both greigite and magnetite in their magnetosomes (e.g., Candidatus 
Desulfamplus magnetomortis strain BW-1). The complex metabolic mechanisms involved in the 
regulation of these features might be related to the presence of a large number of ORFs containing PKS 
and NRPS domains within the genomes of these MTB. Among the magnetotactic Deltaproteobacteria 
is also the freshwater, sulfate-reducing bacterium Desulfovibrio magneticus which synthesizes  
bullet-shaped magnetite magnetosomes [23]. Although a high number of transposable elements are 
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present in its genome [159], we could not identify ORFs containing PKS or NRPS domains, indicating 
that this bacterium does not have a strong potential for the production of secondary metabolites. 
The most promising marine magnetotactic candidate for the production of secondary metabolites 
appears to be Magnetovibrio blakemorei strain MV-1 which is the most metabolically versatile 
magnetotactic bacterium [17] and has been mass cultured to large scale [39]. A large gene cluster 
containing seven ORFs with PKS-NRPS domains (Figure 7) is present in the genome of Mv. blakemorei. 
The longest ORF (6560 amino acids) in this cluster encodes a multi-domain protein whose highest degree 
of similarity is to a protein of unknown function present in Ms. gryphiswaldense (identity 51%, coverage 
98%). Proteins encoded by two other ORFs (4345 and 2570 amino acids) in the same cluster are similar 
to beta-ketoacyl synthase found in Ms. gryphiswaldense MSR-1 (identity 51%, coverage 98%) and 
Oceanibaculum indicum (identity 55%, coverage 96%), respectively. The four smaller ORFs in the 
cluster include genes that encode for beta-ketoacyl synthase and malonyl CoA-acyl carrier protein, also 
similar to proteins from Ms. gryphiswaldense and O. indicum (similarity higher than 58% and coverage 
98%). It is noteworthy that Magnetospirillum, Magnetovibrio, and Oceanibaculum all phylogenetically 
belong to the family Rhodospirillaceae suggesting that this gene cluster has been in the genomes of these 
organisms for some time and is stable in the genome. Considering that both Ms. gryphiswaldense and 
Mv. blakemorei are already being mass cultured in large scale for the production of magnetosomes, this 
cluster of genes deserves further attention. Elucidation of pathways and products in these MTB could 
lead to the co-production of new bioactive molecules in conjunction with magnetosomes. 
 
Figure 7. Cluster of genes containing PKS-NRPS domains in the genome of  
Magnetovibrio blakemorei strain MV-1. Scale bar = 1 Kb. ACP/PCP—acyl carrier 
protein/peptidyl carrier protein; KS—ketosynthase; AT—acyltransferase; DH—dehydratase; 
KR—β-ketoreductase; AMP—adenosine monophosphate; ACPS/cMT—acyl carrier protein 
synthase/c-methyl transferase. 
4. Conclusions 
Magnetotactic bacteria are ubiquitous in marine and freshwater sediments and biomineralize 
magnetosomes, magnetic nanocrystals of magnetite or greigite enveloped by a lipid bilayer derived from 
the cytoplasmic membrane. This ability to synthesize magnetosomes has stimulated and motivated a 
great deal of research involving diverse commercial, scientific and biomedical applications of MTB that 
require or could be improved using magnetic nanocrystals. The synthesis of magnetosomes is genetically 
controlled and results in the biomineralization of single magnetic domains: permanent magnetic crystals 
that have a high degree of crystallographic perfection and consistent sizes and morphologies. Because 
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of the magnetosome lipid bilayer, the crystals are biocompatible and can be modified in numerous ways. 
These characteristics are important in biotechnological applications of magnetic nanoparticles and are 
not all generally obtained in chemically-produced magnetic nanocrystals. Major drawbacks to the 
widespread application of magnetosomes involve the fastidiousness of MTB regarding growth, which 
makes them difficult to culture on a large scale, and the need to fully understand the genetic/ 
environmental control over magnetosome synthesis. However, these limitations are constantly being 
addressed by numerous researchers. The description of MTB as well as the increasing availability of 
sequenced genomes contributes to the optimization and scaling of magnetotactic cell cultivation. 
Moreover, economic feasibility of magnetosome production in large scale might be achieved through 
the co-production of magnetosomes and other metabolic products of high added-value. The marine 
magnetotactic strain Magnetovibrio blakemorei and the freshwater Magnetospirillum gryphiswaldense 
are amenable to cultivation in large scale and their genomes clearly reveal their potential to produce 
secondary metabolites under as yet unknown conditions. The combination of genomic and growth 
studies on MTB are necessary to overcome the difficulties currently inherent in handling MTB and to 
create an economically viable production of magnetosomes. 
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